Novartis Defeats Aredia-Zometa Suit Over Jaw Damage

Law360, New York (October 5, 2012, 4:50 PM EDT) -- Novartis Pharmaceuticals Corp. escaped a lawsuit over alleged jaw damage caused by its Aredia and Zometa bone drugs after crippling expert witnesses' credibility, and it appears likely to beat a similar case after additional success in undermining a doctor's testimony, the company said Friday.

In the first case, a federal judge on Oct. 1 granted summary judgment to the drugmaker after blocking testimony from five treating physicians and one retained expert of Washington state resident Duane E. Luttrell, saying they either lacked qualifications or had not...
To view the full article, register now.